Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Noosa News15 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News21 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business20 hours agoAre BHP shares are buy after its results?
-
Business11 hours agoWhere next for the CBA share price?